Skip to main content
. 2020 Sep 30;45(5):758–767. doi: 10.1159/000510565

Fig. 2.

Fig. 2

Correlation of BSAP and BMD in denosumab-naïve patients. Dots show the absolute change in BSAP at 3 months versus the percentage change in BMD at 6 months and the line shows the average trend by using locally weighted regression (loess) with a span (degree of smoothing) of 0.85. Spearman's rho was −0.476 for total hip and −0.506 for lumbar spine. BSAP, bone-specific alkaline phosphatase; BMD, bone mineral density.